Nippon Kayaku Co (4272) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Aug, 2025Executive summary
Net sales rose to ¥53.6 billion in FY2025 1Q, up 10.4% year-over-year, driven by strong Mobility & Imaging and Fine Chemicals segments, while Life Science underperformed.
Operating income increased by 77.6% year-over-year to ¥7.7 billion, with ordinary income up 74.2% to ¥7.3 billion, aided by foreign exchange gains.
Profit attributable to owners of parent rose 34.0% to ¥3.6 billion, despite a valuation loss on investment securities.
Growth was driven by overseas demand and yen weakness, offsetting Life Science and real estate segment underperformance.
Financial highlights
Net sales: ¥53.6 billion (up ¥5.1 billion, +10.4% YoY).
Operating income: ¥7.7 billion (up ¥3.4 billion, +77.6% YoY).
Ordinary income: ¥7.3 billion (up ¥3.1 billion, +74.2% YoY).
Gross profit increased to ¥17.2 billion from ¥14.3 billion YoY.
Comprehensive income declined to ¥9.4 billion from ¥12.8 billion YoY, mainly due to lower other comprehensive income.
Outlook and guidance
Full-year net sales forecast revised upward to ¥220.8 billion (+5.1% from previous forecast, up 9.4% YoY).
Full-year operating income forecast raised to ¥27.4 billion (+25.6%), with profit attributable to owners of parent at ¥12.0 billion (up 191.7%).
Upward revisions reflect robust automotive and semiconductor markets, improved product mix, and recovery in demand.
Management notes risks from geopolitical factors and FX volatility.
Latest events from Nippon Kayaku Co
- Profit attributable to owners of parent rose 30.1% on 4.0% sales growth, outlook steady.4272
Q3 20262 Feb 2026 - Net sales up 4.1% and profit nearly doubled on investment gains despite cost pressures.4272
Q2 202612 Nov 2025 - Sharp profit growth and raised forecasts driven by Mobility & Imaging and Fine Chemicals.4272
Q3 202519 Aug 2025 - Sales and operating income surged, with upward guidance and major treasury stock buybacks.4272
Q2 202519 Aug 2025 - Record profit and strong segment growth; FY 2026 sees sales up, profit slightly down.4272
Q4 202519 Aug 2025 - Sales rose but profits fell amid higher costs and global risks; outlook remains cautious.4272
Q1 202619 Aug 2025